RBC Capital Markets Initiates AstraZeneca Coverage at Outperform

08:30 AM EDT, 09/09/2026 (MT Newswires) -- RBC Capital Markets on Tuesday started coverage of pharmaceutical company AstraZeneca (AZN.ST, AZN.L) with an outperform rating and a price target of 145 pounds sterling. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)